﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Society of Diabetic Nephropathy Prevention</PublisherName>
      <JournalTitle>Journal of Nephropharmacology</JournalTitle>
      <Issn>2345-4202</Issn>
      <Volume>7</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2018</Year>
        <Month>05</Month>
        <DAY>20</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Diagnosis and predictive clinical and para-clinical cutoffs for diabetes complications in Lur and Lak populations of Iran; a ROC curve analysis to design a regional guideline</ArticleTitle>
    <FirstPage>83</FirstPage>
    <LastPage>89</LastPage>
    <ELocationID EIdType="doi">10.15171/npj.2018.19</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Babak</FirstName>
        <LastName>Khodadadi</LastName>
      </Author>
      <Author>
        <FirstName>Nazanin</FirstName>
        <LastName>Mousavi</LastName>
      </Author>
      <Author>
        <FirstName>Mahshad</FirstName>
        <LastName>Mousavi</LastName>
      </Author>
      <Author>
        <FirstName>Parastoo</FirstName>
        <LastName>Baharvand</LastName>
      </Author>
      <Author>
        <FirstName>Seyyed Amir Yasin</FirstName>
        <LastName>Ahmadi</LastName>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.15171/npj.2018.19</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2018</Year>
        <Month>02</Month>
        <Day>11</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2018</Year>
        <Month>07</Month>
        <Day>25</Day>
      </PubDate>
    </History>
    <Abstract>Introduction: American Diabetes Association updates its guideline every year. However this guideline can be changed for different populations based on their cultural and genetic status. Objectives: We intend to design a regional study in Lur and Lak populations of Iran using receiver operating characteristics (ROC) curve model. Results: For neuropathy, age was the most accurate diagnostic index (area under curve [AUC] = 79%). For nephropathy SBP was the most accurate diagnostic index (AUC= 88%). For symptomatic retinopathy DM duration was the most accurate diagnostic index (AUC= 81%). For PVD, HDL-C was the most accurate diagnostic index (reverse AUC= 67%). For CVD age was the most accurate diagnostic index (AUC= 81%). For foot ulcer history age was the most accurate diagnostic index (AUC= 85%). Conclusion: The final suggested guideline is like the international guidelines. However some unique points should be regarded. Blood pressure &gt;165/110 mm Hg is diagnostic of diabetic nephropathy. Additionally serum high-density lipoprotein (HDL-C) &gt;48 mg/dL is strongly suggested.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Diabetes complications</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Diabetic nephropathy</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Diabetes mellitus</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Microvascular complications</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Cardiovascular disease</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Peripheral vessel disease</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>